Conversely, TP73-AS1 over-expression inhibited the mTOR pathway, proving that the mTOR pathway was involved in the regulation of TP73-AS1 on ccRCC (Liu et al., 2018). This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.